ACA insurers propose biggest premium hikes since 2018 as Trump policies take hold

Affordable Care Act insurers are proposing their steepest premium increases since 2018, with a typical 15% hike and over a quarter seeking 20% or more, according to a KFF analysis. These significant rate adjustments are primarily driven by the impending expiration of Biden-era enhanced premium subsidies, which could lead to a 75% average payment spike for enrollees and potentially deter healthier individuals from coverage, alongside anticipated Trump administration pharmaceutical import tariffs and rising healthcare costs. This situation creates market uncertainty and regulatory challenges as insurers finalize rates ahead of open enrollment, potentially impacting enrollment stability and the overall viability of the ACA market.

Analysis

Affordable Care Act (ACA) insurers are proposing their most significant premium increases since 2018, with a typical rate hike of 15% and over a quarter of filings seeking increases of 20% or more. This pricing pressure stems from a confluence of factors, most notably the scheduled expiration of enhanced premium subsidies at the end of the year. Insurers are preemptively pricing in a 4% average rate increase to counteract the anticipated adverse selection, where healthier individuals may drop coverage following an expected 75% average spike in their out-of-pocket premium payments. This policy-driven uncertainty is compounded by anticipated Trump administration tariffs on pharmaceutical imports, which some insurers cite as adding 3% to their proposals, and underlying healthcare cost inflation, which accounts for approximately half of the requested hikes. The situation's volatility is underscored by Aetna's announced departure from the ACA individual market in 2026, a move signaling perceived instability from a major market participant. While proposed rates are still preliminary and subject to regulatory review, the filings reflect a market bracing for significant disruption driven by fiscal policy changes and regulatory ambiguity.

Key Decisions for Investors

• Investors in managed care organizations should closely monitor any legislative action on extending the ACA subsidies, as a failure to do so validates the defensive premium hikes, while a last-minute extension could create a significant profitability tailwind for 2025.
• The potential for a 75% average premium payment spike for 24 million enrollees represents a material risk to consumer discretionary spending and should be factored into macro outlooks for late 2025 and 2026 if subsidies expire.
• Aetna's planned exit from the ACA marketplace should be viewed as a strategic de-risking move; investors should scrutinize the exchange exposure and pricing strategy of other publicly-traded insurers to gauge their vulnerability to this market instability.
• Given the high degree of policy uncertainty surrounding subsidies and tariffs, a cautious stance on the ACA-exposed managed care sub-sector is warranted until final rates are published and legislative outcomes become clear.